Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWITCH III: Switching from Fondaparinux to Bivalirudin or Heparin in ACS PCI
NCT00464087Phase 3Completed
- Sponsor
- MedStar Health Research Institute
- Start
- Jun 2007
- Primary completion
- Nov 2010
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of bivalirudin in acute coronary syndrome (ACS), sponsored by MedStar Health Research Institute. Started Jun 2007; status: completed.
02
Drugs
bivalirudin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00464087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00464087.